Riskpilot← Back to searchSign inGet full accessAbbVie AB
ABActiveOrg 5568875651Hagaplan 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2012180 employees
Revenue 2024
SEK 1B
+6% vs 2023
EBITDA margin
64.1%
+1% vs 2023
Equity ratio
85.7%
Financial strength
Net profit 2024
SEK 541,6M
-1% vs 2023
| Revenue | SEK 1B | +6% |
| EBITDA | SEK 662,1M | +1% |
| Net profit | SEK 541,6M | -1% |
| Total assets | SEK 2,3B | +5% |
| Equity | SEK 2B | +3% |
| Employees | 180 | — |
Legal name
AbbVie AB
Org number
5568875651
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13 mars 2012
Share capital
SEK 50 000
Employees
180 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall importera, tillverka och preparera, i parti och minut försälja, exportera och handla med läkemedel, farmaceutiska preparat och specialiteter, kemikalier, näringspreparat, medicinska produkter av alla slag samt sjukvårdsutensilier, samt bedriva därmed förenlig verksamhet.
Address
Hagaplan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 458 628 | 459 708 | 983 746 | 971 658 | 1 033 078 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 640 665 | 627 017 | 648 313 | 657 939 | 662 134 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 640 665 | 627 017 | 648 313 | 657 939 | 662 134 |
| Net financials | 137 | −124 | 15 580 | 49 587 | 51 152 |
| Profit before tax | 640 802 | 626 893 | 663 893 | 707 526 | 713 286 |
| Tax | −139 337 | −130 625 | −150 098 | −158 936 | −171 696 |
| Net profit | 501 465 | 496 268 | 513 795 | 548 590 | 541 590 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 364 512 | 2 066 681 | 2 514 484 | 2 186 186 | 2 284 791 |
| Equity | 861 284 | 1 765 008 | 2 276 971 | 1 895 561 | 1 957 151 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 502 321 | 300 766 | 236 606 | 289 718 | 327 640 |
| Total debt | 502 321 | 300 766 | 236 606 | 289 718 | 327 640 |
EBITDA margin
64.1%
This company
15.8%
Market median
+306% vs market
20202024
Equity ratio
85.7%
This company
38.2%
Market median
+124% vs market
20202024
Return on equity
27.7%
This company
18.4%
Market median
+51% vs market
20202024
Net profit margin
52.4%
This company
8.1%
Market median
+547% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
IM Chief Auditor | Chief Auditor | 2022 – 2024 |
JE Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ABBVIE CENTRAL FINANCE B.V.
AbbVie AB (this company)Board members of AbbVie AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Erzsébet Magdalena Lennmark | Chief Auditor | 0 companies |
| Ida Maria Brandt | Chief Auditor | 0 companies |
| Johan Erik Sylvén | Chief Auditor | 0 companies |
| Matthew Robert Iles | Chairman | 0 companies |
| Emilie Claudine Demare | Board of Directors | 0 companies |
| Robert Andrew Michael | Board of Directors | 0 companies |
| Shitra Irari Amozurrutia Blancas | Board of Directors | 0 companies |
| Arnaud Coint-Bavarot | Board of Directors | 0 companies |
| Linn Kristina Mandahl | Chairman | 0 companies |
| Jens Lange | Board of Directors | 0 companies |